A Novel Pyroptosis-Based Prognostic Model Correlated with the Parainflammatory Immune Microenvironment of Pancreatic Cancer

Background. Pyroptosis has a dual function in malignant tumor progression and management. The action of pyroptosis-related genes (PRGs) in pancreatic cancer (PC), however, remains uncertain. Methods. Differential expression analyses of 57 PRGs were conducted in the TCGA TARGET GTEx dataset. The cand...

Full description

Saved in:
Bibliographic Details
Main Authors: Kong-kong Wei, Zhi-xing Du, Jun-ge Deng, Jin-wei Yang, Hao Chen
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2023/8776892
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558555731853312
author Kong-kong Wei
Zhi-xing Du
Jun-ge Deng
Jin-wei Yang
Hao Chen
author_facet Kong-kong Wei
Zhi-xing Du
Jun-ge Deng
Jin-wei Yang
Hao Chen
author_sort Kong-kong Wei
collection DOAJ
description Background. Pyroptosis has a dual function in malignant tumor progression and management. The action of pyroptosis-related genes (PRGs) in pancreatic cancer (PC), however, remains uncertain. Methods. Differential expression analyses of 57 PRGs were conducted in the TCGA TARGET GTEx dataset. The candidate genes were determined using LASSO Cox regression and random forest analyses. A risk model was developed with the TCGA dataset and validated with the ICGC dataset. Results. Three prognosis-related PRGs (BAK1, GSDMC, and IL18) were chosen to create a risk model. High-risk patients from the TCGA and ICGC cohorts had an unfavorable overall survival (all p<0.05). The risk modelʼs accuracy and independent predictability were assessed by receiver operating characteristic curves and multivariate Cox regression analysis, respectively. High-risk patients possessed different molecular pathways, higher KRAS and TP53 mutations, increased expression of PD-L1, C1 immune subtype, and immunosuppressive microenvironment characterized by parainflammation compared to low-risk patients. KRAS and TP53 mutations participated in different inflammatory pathways and played different prognostic roles between the two risk groups. KRAS mutations in high-risk patients caused a more unfavorable prognosis than wild-type KRAS (p=0.016), whereas TP53 mutations in low-risk patients exhibited a poorer outcome than wild-type TP53 (p=0.009). Spearman correlation analyses revealed that the parainflammatory response in PC might be implicated in GSDMC-mediated pyroptosis via cytosolic DNA-sensing pathways under hypoxic conditions. Furthermore, the risk scores were significantly and positively related to the expression of HNRNPC, RBM15, YTHDF1, and YTHDF2, as well as sensitivity to gemcitabine, cisplatin, and erlotinib. Conclusions. This study created a novel pyroptosis-based risk model related to the parainflammatory immune microenvironment, which might help identify novel biomarkers, evaluate the tumor immune microenvironment, and develop management strategies for PC patients.
format Article
id doaj-art-dd20bbb230fc4b35a50cf1b5f2cf5aca
institution Kabale University
issn 2314-7156
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-dd20bbb230fc4b35a50cf1b5f2cf5aca2025-02-03T01:32:07ZengWileyJournal of Immunology Research2314-71562023-01-01202310.1155/2023/8776892A Novel Pyroptosis-Based Prognostic Model Correlated with the Parainflammatory Immune Microenvironment of Pancreatic CancerKong-kong Wei0Zhi-xing Du1Jun-ge Deng2Jin-wei Yang3Hao Chen4Department of Surgical OncologyDepartment of Surgical OncologyDepartment of Surgical OncologyDepartment of Surgical OncologyDepartment of Surgical OncologyBackground. Pyroptosis has a dual function in malignant tumor progression and management. The action of pyroptosis-related genes (PRGs) in pancreatic cancer (PC), however, remains uncertain. Methods. Differential expression analyses of 57 PRGs were conducted in the TCGA TARGET GTEx dataset. The candidate genes were determined using LASSO Cox regression and random forest analyses. A risk model was developed with the TCGA dataset and validated with the ICGC dataset. Results. Three prognosis-related PRGs (BAK1, GSDMC, and IL18) were chosen to create a risk model. High-risk patients from the TCGA and ICGC cohorts had an unfavorable overall survival (all p<0.05). The risk modelʼs accuracy and independent predictability were assessed by receiver operating characteristic curves and multivariate Cox regression analysis, respectively. High-risk patients possessed different molecular pathways, higher KRAS and TP53 mutations, increased expression of PD-L1, C1 immune subtype, and immunosuppressive microenvironment characterized by parainflammation compared to low-risk patients. KRAS and TP53 mutations participated in different inflammatory pathways and played different prognostic roles between the two risk groups. KRAS mutations in high-risk patients caused a more unfavorable prognosis than wild-type KRAS (p=0.016), whereas TP53 mutations in low-risk patients exhibited a poorer outcome than wild-type TP53 (p=0.009). Spearman correlation analyses revealed that the parainflammatory response in PC might be implicated in GSDMC-mediated pyroptosis via cytosolic DNA-sensing pathways under hypoxic conditions. Furthermore, the risk scores were significantly and positively related to the expression of HNRNPC, RBM15, YTHDF1, and YTHDF2, as well as sensitivity to gemcitabine, cisplatin, and erlotinib. Conclusions. This study created a novel pyroptosis-based risk model related to the parainflammatory immune microenvironment, which might help identify novel biomarkers, evaluate the tumor immune microenvironment, and develop management strategies for PC patients.http://dx.doi.org/10.1155/2023/8776892
spellingShingle Kong-kong Wei
Zhi-xing Du
Jun-ge Deng
Jin-wei Yang
Hao Chen
A Novel Pyroptosis-Based Prognostic Model Correlated with the Parainflammatory Immune Microenvironment of Pancreatic Cancer
Journal of Immunology Research
title A Novel Pyroptosis-Based Prognostic Model Correlated with the Parainflammatory Immune Microenvironment of Pancreatic Cancer
title_full A Novel Pyroptosis-Based Prognostic Model Correlated with the Parainflammatory Immune Microenvironment of Pancreatic Cancer
title_fullStr A Novel Pyroptosis-Based Prognostic Model Correlated with the Parainflammatory Immune Microenvironment of Pancreatic Cancer
title_full_unstemmed A Novel Pyroptosis-Based Prognostic Model Correlated with the Parainflammatory Immune Microenvironment of Pancreatic Cancer
title_short A Novel Pyroptosis-Based Prognostic Model Correlated with the Parainflammatory Immune Microenvironment of Pancreatic Cancer
title_sort novel pyroptosis based prognostic model correlated with the parainflammatory immune microenvironment of pancreatic cancer
url http://dx.doi.org/10.1155/2023/8776892
work_keys_str_mv AT kongkongwei anovelpyroptosisbasedprognosticmodelcorrelatedwiththeparainflammatoryimmunemicroenvironmentofpancreaticcancer
AT zhixingdu anovelpyroptosisbasedprognosticmodelcorrelatedwiththeparainflammatoryimmunemicroenvironmentofpancreaticcancer
AT jungedeng anovelpyroptosisbasedprognosticmodelcorrelatedwiththeparainflammatoryimmunemicroenvironmentofpancreaticcancer
AT jinweiyang anovelpyroptosisbasedprognosticmodelcorrelatedwiththeparainflammatoryimmunemicroenvironmentofpancreaticcancer
AT haochen anovelpyroptosisbasedprognosticmodelcorrelatedwiththeparainflammatoryimmunemicroenvironmentofpancreaticcancer
AT kongkongwei novelpyroptosisbasedprognosticmodelcorrelatedwiththeparainflammatoryimmunemicroenvironmentofpancreaticcancer
AT zhixingdu novelpyroptosisbasedprognosticmodelcorrelatedwiththeparainflammatoryimmunemicroenvironmentofpancreaticcancer
AT jungedeng novelpyroptosisbasedprognosticmodelcorrelatedwiththeparainflammatoryimmunemicroenvironmentofpancreaticcancer
AT jinweiyang novelpyroptosisbasedprognosticmodelcorrelatedwiththeparainflammatoryimmunemicroenvironmentofpancreaticcancer
AT haochen novelpyroptosisbasedprognosticmodelcorrelatedwiththeparainflammatoryimmunemicroenvironmentofpancreaticcancer